| __timestamp | ACADIA Pharmaceuticals Inc. | BioMarin Pharmaceutical Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 60602000 | 461543000 |
| Thursday, January 1, 2015 | 73869000 | 634806000 |
| Friday, January 1, 2016 | 99284000 | 661905000 |
| Sunday, January 1, 2017 | 149189000 | 610753000 |
| Monday, January 1, 2018 | 187163000 | 696328000 |
| Tuesday, January 1, 2019 | 240385000 | 715007000 |
| Wednesday, January 1, 2020 | 319130000 | 628116000 |
| Friday, January 1, 2021 | 239415000 | 628793000 |
| Saturday, January 1, 2022 | 361575000 | 649606000 |
| Sunday, January 1, 2023 | 351619000 | 746773000 |
| Monday, January 1, 2024 | 747184000 |
Unleashing insights
In the competitive landscape of biopharmaceuticals, strategic investment in research and development (R&D) is crucial for innovation and growth. Over the past decade, BioMarin Pharmaceutical Inc. and ACADIA Pharmaceuticals Inc. have demonstrated contrasting approaches to R&D spending. From 2014 to 2023, BioMarin consistently allocated a significant portion of its resources to R&D, with expenditures peaking at approximately 750 million in 2023, marking a 62% increase from 2014. In contrast, ACADIA's R&D spending surged by nearly 480% over the same period, reaching its zenith in 2022. This strategic focus underscores the companies' commitment to pioneering new treatments and maintaining a competitive edge. As the biopharma industry continues to evolve, these investments highlight the importance of R&D in driving innovation and ensuring long-term success.
R&D Spending Showdown: Alnylam Pharmaceuticals, Inc. vs ACADIA Pharmaceuticals Inc.
Analyzing R&D Budgets: BioMarin Pharmaceutical Inc. vs Alkermes plc
BioMarin Pharmaceutical Inc. or Lantheus Holdings, Inc.: Who Invests More in Innovation?
Research and Development Investment: BioMarin Pharmaceutical Inc. vs Travere Therapeutics, Inc.
BioMarin Pharmaceutical Inc. or Evotec SE: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Sarepta Therapeutics, Inc. vs ACADIA Pharmaceuticals Inc.
Comparing Innovation Spending: Halozyme Therapeutics, Inc. and ACADIA Pharmaceuticals Inc.
Comparing Innovation Spending: Blueprint Medicines Corporation and ACADIA Pharmaceuticals Inc.
R&D Spending Showdown: CRISPR Therapeutics AG vs ACADIA Pharmaceuticals Inc.
Who Prioritizes Innovation? R&D Spending Compared for ACADIA Pharmaceuticals Inc. and Iovance Biotherapeutics, Inc.
Comparing Innovation Spending: ACADIA Pharmaceuticals Inc. and Dynavax Technologies Corporation
ACADIA Pharmaceuticals Inc. vs Celldex Therapeutics, Inc.: Strategic Focus on R&D Spending